haemato-oncology

Oncology

Abstract illustration of targeting cancer cell

How automating flow cytometry is revolutionising cancer diag...

As the incidence of cancer rises around the world, the demand for faster, more precise diagnoses is also on the rise.

Oncology

ASCO 2024: Emphasising the art and science behind enhanced c...

The term “practice-changing” is often used when scientific advances promise to shift traditional treatment paradigms.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Oncology

Clinical decision-making insights for haem/oncs

Despite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several decision-making challenges for healthcare professionals.

Partner Content

Partner Content

When science and biology combine – the outlook for ADCs in c...

Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents.

News

FDA reapproves Pfizer's Mylotarg leukaemia drug

FDA gives green light after 7-year absence

How automating flow cytometry is revolutionising cancer diag...

ASCO 2024: Emphasising the art and science behind enhanced c...

Clinical decision-making insights for haem/oncs

When science and biology combine – the outlook for ADCs in c...

FDA reapproves Pfizer's Mylotarg leukaemia drug

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

haemato-oncology

Editor's Picks